ClinicalTrials.Veeva

Menu
S

Syneos Health | Miami, USA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

H008
LY5625575
D-0120
Plavix®
Diphenhydramine Hydrochloride
RP-G28
Ibuprofen
CG-0255 Besylate
HNC1058
TLC599

Parent organization

This site is a part of Syneos Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)

The main purpose of this study is to evaluate the safety and tolerability of LY5625575 in healthy participants (including Japanese and Chinese) and i...

Not yet enrolling
Healthy Volunteers
C-Reactive Protein
Drug: Placebo
Drug: LY5625575

CG-0255 is a novel investigational prodrug of the active metabolite of Plavix®, but with different active metabolite conversion routes. This is a ran...

Enrolling
Recent Myocardial Infarction
Acute Coronary Syndromes (ACS)
Drug: CG-0255 Besylate Capsule
Drug: Clopidogrel

Trial sponsors

C
G
Haleon logo
I
Lilly logo
Pfizer logo
R
T
N
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems